Bilastine and Montelukast in patients with seasonal allergic rhinoconjunctivitis and asthma: Efficacy of concomitant administration; the SKY study

Trial Profile

Bilastine and Montelukast in patients with seasonal allergic rhinoconjunctivitis and asthma: Efficacy of concomitant administration; the SKY study

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jun 2017

At a glance

  • Drugs Bilastine (Primary) ; Montelukast (Primary)
  • Indications Allergic rhinoconjunctivitis; Asthma; Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Acronyms SKY
  • Sponsors Menarini
  • Most Recent Events

    • 16 Jan 2017 Status changed from active, no longer recruiting to completed.
    • 13 Dec 2016 This trial has been completed Poland (end date: 2016-11-23)
    • 03 Dec 2016 This trial has been completed Czech Republic (end date: 2016-11-23)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top